Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ethinylestradiol 0.035mg (approx. 3% overage added);  ; norethisterone 1mg;  ;   - tablet - active: ethinylestradiol 0.035mg (approx. 3% overage added)   norethisterone 1mg     excipient: lactose monohydrate magnesium stearate maize starch povidone lactose lactose monohydrate as the monohydrate magnesium stearate microcrystalline cellulose sunset yellow fcf as fd&c yellow #6 lake - contraception.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ethinylestradiol 0.035mg (approx. 3% overage added);  ; norethisterone 0.5mg;  ;   - tablet - active: ethinylestradiol 0.035mg (approx. 3% overage added)   norethisterone 0.5mg     excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone - contraception

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

bayer new zealand limited - cyproterone acetate 2mg; ethinylestradiol 0.035mg - film coated tablet - active: cyproterone acetate 2mg ethinylestradiol 0.035mg excipient: calcium carbonate glycerol glycol montanate iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose titanium dioxide calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose - · the treatment of signs of androgenisation in women, such as severe acne (involving inflammation or nodularity or risk of scarring) where prolonged oral antibiotics or local treatment alone has not been successful, or idiopathic hirsutism of mild to moderate degree.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cyproterone acetate 2mg;  ; ethinylestradiol 0.035mg;   - film coated tablet - active: cyproterone acetate 2mg   ethinylestradiol 0.035mg   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry buff oy-3690 opadry white y-1r-7000b opaglos white 6000 povidone purified water quinoline yellow sucrose lactose monohydrate magnesium stearate microcrystalline cellulose - estelle-35 and estelle-35 ed are indicated for the treatment of androgen dependent diseases in women, such as acne (where oral antibiotics or local treatment alone has not been successful), especially pronounced forms and those which are accompanied by seborrhoea or by inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica), androgenic alopecia, mild forms of hirsutism. estelle-35 and estelle-35 ed are also indicated for oral contraception in women requiring treatment for these androgen-dependent diseases; it is not recommended in women solely for contraception. estelle-35 and estelle-35 ed are also indicated for treating the symptoms of polycystic ovary syndrome.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

viatris limited - itraconazole 100mg;   - capsule - 100 mg - active: itraconazole 100mg   excipient: capsugel red g60csa00150 colloidal silicon dioxide ethanol gelatin hypromellose iron oxide red methylene chloride opacode white s-1-7078 purified water sorbitan stearate sugar spheres titanium dioxide - itraconazole capsules are indicated for the treatment of: · vulvovaginal candidiasis. · pityriasis versicolor, · dermatomycosis - including highly keratinised regions as in plantar tinea pedis and palmer tinea manus, · fungal keratitis, · oral candidiasis, · onychomycosis caused by dermatophytes and/or yeasts. · systemic mycoses, only in the following fungal infections: - systemic aspergillosis - histoplasmosis, - histoplasmosis, maintenance therapy only in aids patients - sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous) - paraconccidioidomycosis, - chromomycosis, - blastomycosis

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

bayer new zealand limited - ethinylestradiol 30ug; levonorgestrel 150ug - tablet - active: ethinylestradiol 30ug levonorgestrel 150ug excipient: calcium carbonate glycerol glycol montanate iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose titanium dioxide calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose - oral contraception.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ethinylestradiol 20ug; levonorgestrel 100ug; ethinylestradiol 0.02mg; levonorgestrel 0.1mg - film coated tablet - active: ethinylestradiol 20ug levonorgestrel 100ug excipient: glycol montanate lactose monohydrate macrogols magnesium stearate microcrystalline cellulose opadry pink ys-1-14587-a polacrilin potassium glycol montanate lactose monohydrate macrogol 1500 magnesium stearate microcrystalline cellulose opadry white y-5-18024-a polacrilin potassium aquapolish p white 010.66 magnesium stearate starlac active: ethinylestradiol 0.02mg levonorgestrel 0.1mg excipient: wax e pharma lactose magnesium stearate microcrystalline cellulose opadry pink ys-1-14587-a polacrilin potassium polyethylene glycol 1450 purified water wax e pharma lactose macrogol 1500 magnesium stearate microcrystalline cellulose opadry white y-5r-18024-a polacrilin potassium purified water - loette is indicated for the prevention of pregnancy.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

viatris limited - ethinylestradiol 0.02mg; levonorgestrel 0.1mg - film coated tablet - 0.1mg/0.02mg - active: ethinylestradiol 0.02mg levonorgestrel 0.1mg excipient: calcium carbonate   carnauba wax croscarmellose sodium glycerol     iron oxide red   iron oxide yellow   isopropyl alcohol lactose monohydrate macrogol 6000   magnesium stearate microcrystalline cellulose povidone       purified talc     purified water sucrose   titanium dioxide   calcium carbonate   carnauba wax glycerol     iron oxide yellow   lactose monohydrate macrogol 6000   magnesium stearate maize starch povidone       purified talc     purified water     sucrose   titanium dioxide   - oral contraception

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - desogestrel 0.15mg;  ; ethinylestradiol 0.03mg;   - tablet - active: desogestrel 0.15mg   ethinylestradiol 0.03mg   excipient: colloidal silicon dioxide dl-alpha tocopheryl acetate lactose monohydrate magnesium stearate potato starch povidone stearic acid lactose monohydrate magnesium stearate potato starch

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - desogestrel 150ug;  ; ethinylestradiol 20ug;   - tablet - active: desogestrel 150ug   ethinylestradiol 20ug   excipient: colloidal silicon dioxide dl-alpha tocopherol lactose monohydrate magnesium stearate potato starch povidone stearic acid lactose monohydrate magnesium stearate potato starch - oral contraception.